CNR1 and Hepatic steatosis: Overall, these findings pinpoint the dual nature of the eCBS in the pathophysiology of ALD, suggesting a bifaceted strategy toward both an inhibition of hepatic CB1R and the activation of hepatic CB2R to counteract alcohol-related liver steatosis and inflammation (Figure 1).